Company
United StatesAvista Pharma Solutions, Inc. dba Cambrex, Longmont, CO – FDA Inspections
Inspection records and compliance data for Avista Pharma Solutions, Inc. dba Cambrex in Longmont, Colorado. 2 FDA inspections on record, 1 Form 483, last inspected May 03, 2024.
Company Profile
This profile covers Avista Pharma Solutions, Inc. dba Cambrex based in Longmont, Colorado, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 1
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
First inspected November 9, 2018. Last inspected May 3, 2024.
Most cited issue areas
- Laboratory equipment calibration records1 inspection
- Procedures not in writing, fully followed1 inspection
- Scientifically sound laboratory controls1 inspection
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| May 3, 2024 | VAI | Human Drugs · Drug Quality Assurance | 1237587 |
| November 9, 2018 | Not classified | Human Drugs | 1072967 |
FDA documents
Form 483s (1)
EIRs (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Alexion Pharma International Operations Unlimited Co.
BSP Pharmaceuticals SpA
Genzyme Corporation
Abbvie Biotechnology Ltd.
Hovione LLC
Sun Pharmaceutical Medicare Limited
Wacker Biotech B.V.
Boehringer Ingelheim Biopharmaceuticals (China) Ltd.
Regeneron Pharmaceuticals Inc
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Company Information
Name
Avista Pharma Solutions, Inc. dba Cambrex
FEI Number
3012316957
Address
2620 Trade Centre Ave, Longmont, Colorado 80503, United States
Country
United States
ID: ca9e4205-cd7f-44bd-8dbe-a9d98be57047